Updated CDC Recommendation for Serologic Diagnosis of Lyme Disease
- PMID: 31415492
- PMCID: PMC6818702
- DOI: 10.15585/mmwr.mm6832a4
Updated CDC Recommendation for Serologic Diagnosis of Lyme Disease
Abstract
Lyme disease is a tickborne zoonosis for which serologic testing is the principal means of laboratory diagnosis. In 1994, the Association of State and Territorial Public Health Laboratory Directors, CDC, the Food and Drug Administration (FDA), the National Institutes of Health (NIH), the Council of State and Territorial Epidemiologists, and the National Committee for Clinical Laboratory Standards convened the Second National Conference on Serologic Diagnosis of Lyme Disease (1).
Conflict of interest statement
All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
Similar articles
-
New laboratory guidelines for serologic diagnosis of Lyme disease: evaluation of the two-test protocol.J Clin Microbiol. 1996 Oct;34(10):2343-50. doi: 10.1128/jcm.34.10.2343-2350.1996. J Clin Microbiol. 1996. PMID: 8880477 Free PMC article.
-
From the Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.JAMA. 1995 Sep 27;274(12):937. JAMA. 1995. PMID: 7674514 No abstract available.
-
Role of serology in the diagnosis of Lyme disease.JAMA. 1999 Jul 7;282(1):62-6. doi: 10.1001/jama.282.1.62. JAMA. 1999. PMID: 10404913
-
Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States.Emerg Infect Dis. 2016 Jul;22(7):1169-77. doi: 10.3201/eid2207.151694. Emerg Infect Dis. 2016. PMID: 27314832 Free PMC article. Review.
-
[Laboratory diagnosis of infection caused by Borrelia burgdorferi].Ugeskr Laeger. 2006 Aug 21;168(34):2805-7. Ugeskr Laeger. 2006. PMID: 16942701 Review. Danish.
Cited by
-
Establishing a Pregnancy Lyme Disease Biobank.Methods Mol Biol. 2024;2742:245-257. doi: 10.1007/978-1-0716-3561-2_17. Methods Mol Biol. 2024. PMID: 38165627
-
Developing a Prospective Gestational Lyme Disease Study.Methods Mol Biol. 2024;2742:259-278. doi: 10.1007/978-1-0716-3561-2_18. Methods Mol Biol. 2024. PMID: 38165628
-
A Multiplexed Serologic Test for Diagnosis of Lyme Disease for Point-of-Care Use.J Clin Microbiol. 2019 Nov 22;57(12):e01142-19. doi: 10.1128/JCM.01142-19. Print 2019 Dec. J Clin Microbiol. 2019. PMID: 31597750 Free PMC article.
-
Diagnostic Testing for Patients With Suspected Ocular Manifestations of Lyme Disease.Fed Pract. 2025 Jan;42(1):58-61. doi: 10.12788/fp.0547. Epub 2025 Jan 15. Fed Pract. 2025. PMID: 40529603 Free PMC article. Review.
-
Update on North American tick-borne diseases and how to diagnose them.J Clin Microbiol. 2025 Aug 13;63(8):e0080723. doi: 10.1128/jcm.00807-23. Epub 2025 Jul 11. J Clin Microbiol. 2025. PMID: 40643260 Free PMC article. Review.
References
-
- Association of State and Territorial Public Health Laboratory Directors. In: proceedings of the Second National Conference on Serologic Diagnosis of Lyme Disease; October 27–29, 1994; Dearborn, MI. Washington, DC: Association of State and Territorial Public Health Laboratory Directors; 1994.
-
- CDC. Notice to readers: recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995;44:590–1. - PubMed
-
- Food and Drug Administration. FDA clears new indications for existing Lyme disease tests that may help streamline diagnoses. [News release]. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2019. https://www.fda.gov/news-events/press-announcements/fda-clears-new-indic...
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical